Jaguar Health, Inc.
JAGX
$12.98
$1.119.35%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.51M | 3.11M | 2.72M | 2.35M | 2.30M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.51M | 3.11M | 2.72M | 2.35M | 2.30M |
| Cost of Revenue | 557.00K | 541.00K | 427.00K | 430.00K | 687.00K |
| Gross Profit | 2.95M | 2.57M | 2.29M | 1.92M | 1.61M |
| SG&A Expenses | 6.58M | 5.79M | 5.84M | 5.82M | 5.34M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.67M | 10.37M | 9.92M | 10.57M | 9.49M |
| Operating Income | -8.16M | -7.26M | -7.20M | -8.22M | -7.19M |
| Income Before Tax | -10.23M | -10.02M | -9.63M | -9.37M | -9.31M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.23M | -10.02M | -9.63M | -9.37M | -9.31M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 314.00K | 167.00K | 136.00K | 142.00K | 139.00K |
| Net Income | -9.92M | -9.85M | -9.49M | -9.23M | -9.17M |
| EBIT | -8.16M | -7.26M | -7.20M | -8.22M | -7.19M |
| EBITDA | -7.68M | -6.79M | -6.75M | -7.71M | -6.68M |
| EPS Basic | -20.83 | -26.29 | -101.00 | -87.12 | -281.43 |
| Normalized Basic EPS | -12.77 | -16.26 | -62.58 | -61.30 | -167.18 |
| EPS Diluted | -20.83 | -26.29 | -101.00 | -90.00 | -281.43 |
| Normalized Diluted EPS | -12.77 | -16.26 | -62.58 | -61.30 | -167.18 |
| Average Basic Shares Outstanding | 476.30K | 374.80K | 94.00K | 105.90K | 32.60K |
| Average Diluted Shares Outstanding | 476.30K | 374.80K | 94.00K | 105.90K | 32.60K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |